Search results
AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful...
NewMediaWire via Yahoo Finance· 3 months agoThe Company's Commercialization Partner Versa Ophthalmic Places Re-stock Order of AXIM's Digital...
Update: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to...
NewMediaWire via Yahoo Finance· 10 months agoLeading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full...
AXIM Biotechnologies CEO Issues Letter to Shareholders
NewMediaWire via Yahoo Finance· 1 year agoSummary: In 2022, AXIM(R) finalized optimization of its R&D and manufacturing infrastructure to be...
AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to...
NewMediaWire via Yahoo Finance· 1 year agoSan Diego, CA - (NewMediaWire) - January 17, 2023 - AXIM Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM...